ClinicalTrials.gg
CompletedNCT06227871Updated Jan 29, 2024

A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes

An observational study in Pancreatic Trauma, Pancreatic Duct Injury and Pancreas Necrosis, sponsored by Kern Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-29.

Sponsored by Kern Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
31
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to compare the presentation, treatment, and outcomes in patients suffering traumatic pancreatic injuries from blunt or penetrating trauma.

The questions this study aims to answer are:

  1. Does a statistically significant association exist between pancreatic injury grade and the following individual factors:

    • Mortality
    • Morbidity
    • Injury severity score
  2. Is there an association between post-operative pancreatic complications and operation-specific intervention?
  3. Does pancreatic injury score correlate with certain intra-abdominal organ injuries?

Participants meeting criteria are greater than 18 years old, with no history of pancreatic surgery who were hospitalized at Kern Medical Center after presenting to the institution's emergency department as tier 1 or 2 trauma activations following blunt or penetrating abdominal injury and were diagnosed with pancreatic injury during the same hospitalization.

02

Conditions studied

  • Pancreatic Trauma
  • Pancreatic Duct Injury
  • Pancreas Necrosis
  • Pancreas Cyst
  • Pancreas; Fistula
  • Pancreas Abscess
  • Intra-Abdominal Abscess
  • Anastomotic Leak
  • Pancreas Injury

Keywords

  • Pancreatic trauma
  • Penetrating abdominal injury
  • Abdominal trauma
03

In context

Pancreatitis, Acute Necrotizing

74 studies on the registry are indexed under Pancreatitis, Acute Necrotizing; 19 are open to participants now.

This study's enrollment of 31 is below the median of 100 across 25 observational studies indexed under Pancreatitis, Acute Necrotizing.

Browse Pancreatitis, Acute Necrotizing studies →

Lead sponsor

Kern Medical Center is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient's greater than 18 years old, with no history of pancreatic surgery who were hospitalized at Kern Medical Center from November 1st, 2019 to March 1st, 2023 after presenting to the institution's emergency department as tier 1 and 2 trauma activations following blunt or penetrating abdominal injury and were diagnosed with pancreatic injury during the same hospitalization.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hospitalized at Kern Medical Center after presenting to the institution's emergency department as a tier 1 and 2 trauma activation
  • Hospitalized following blunt or penetrating abdominal injury
  • Diagnosed with traumatic pancreatic injury during same admission

Exclusion criteria

Exclusion Criteria:

  • history of pancreatic surgery
  • Iatrogenic pancreatic injuries
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
31 participants (actual)
Patient registry
No

Groups and cohorts

  • Penetrating intra-abdominal injury

    Patients diagnosed with a pancreatic injury secondary to penetrating intra-abdominal injury subdivided by pancreatic injury grade

    Procedure: Exploratory laparotomy

  • Blunt intra-abdominal injury

    Patients diagnosed with a pancreatic injury secondary to blunt intra-abdominal injury subdivided by pancreatic injury grade

    Procedure: Exploratory laparotomy

Interventions

  • ProcedureExploratory laparotomy

    Exploratory laparotomy with interventions addressing pancreatic injuries Grade 1-5 including pancreatic interventions including subtotal pancreatectomy, distal pancreatectomy, pancreatic ligation, pyloric diversion, or simple drainage of the pancreas.

06

What researchers measure

Primary outcomes

  1. Complication occurrence

    Complications including wound dehiscence, pancreatic duct leak, pancreatic pseudocyst, pancreatic fistula formation, pancreatic necrosis, intra-abdominal abscess, traumatic pancreatitis, anastomotic leak

    Time frame: Up to 12 weeks postoperatively

Secondary outcomes

  1. Associated intra-abdominal injuries

    concomitant intra-abdominal injuries including pancreatic duck, diaphragm, stomach, liver, kidney, Major vasculature, spleen, duodenum, small bowel, colon, ureter

    Time frame: within 48 hours of admission

07

Study locations

1 site
  • Kern Medical Center
    Bakersfield, California 93306, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06227871
Lead sponsor
Kern Medical Center
Responsible party
Amber Jones (Principal Investigator, DO, MPH, Kern Medical Center) — Principal investigator
First posted
Jan 29, 2024
Start date
Nov 1, 2019
Primary completion
Mar 1, 2023
Completion
Mar 1, 2023
Last update
Jan 29, 2024

Study contacts

Amber Jones, DO, MPH
principal investigator · Kern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion